Comparative analysis of the frequency of comorbid diseases in axial psoriatic arthritis and other variants of axial spondyloarthritis. Data from a hospital cohort

Objective: to compare the frequency of comorbid diseases in axial psoriatic arthritis (axSpA) and in other variants (OV) of axial spondyloarthritis (axSpA).Material and methods. We studied 60 patients, 30 with axPsA (15 men and 15 women, mean age – 49.1±10.4 years, disease duration – 12.6±6.9 years)...

Full description

Saved in:
Bibliographic Details
Main Authors: A. A. Yanushonite, Yu. L. Korsakova, T. V. Korotaeva, E. E. Gubar, E. Yu. Loginova, M. M. Urumova, A. E. Dimitreva, S. I. Glukhova
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2024-10-01
Series:Современная ревматология
Subjects:
Online Access:https://mrj.ima-press.net/mrj/article/view/1636
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849242092925091840
author A. A. Yanushonite
Yu. L. Korsakova
T. V. Korotaeva
E. E. Gubar
E. Yu. Loginova
M. M. Urumova
A. E. Dimitreva
S. I. Glukhova
author_facet A. A. Yanushonite
Yu. L. Korsakova
T. V. Korotaeva
E. E. Gubar
E. Yu. Loginova
M. M. Urumova
A. E. Dimitreva
S. I. Glukhova
author_sort A. A. Yanushonite
collection DOAJ
description Objective: to compare the frequency of comorbid diseases in axial psoriatic arthritis (axSpA) and in other variants (OV) of axial spondyloarthritis (axSpA).Material and methods. We studied 60 patients, 30 with axPsA (15 men and 15 women, mean age – 49.1±10.4 years, disease duration – 12.6±6.9 years) and 30 with OV axSpA (16 men and 14 women, mean age – 42.9±9.7 years, disease duration – 16.30±8.3 years). All patients underwent a standard rheumatological examination. The diagnosis of comorbid diseases was confirmed using ICD-10 codes. The Cumulative Illness Rating Scale (CIRS), Charlson comorbidity index (CCI) and the weighted version of Functional Comorbidity Index (w-FCI) were used to assess comorbidity.Results and discussion. Comparative analysis of the two groups revealed that axPsA patients were older than OV axSpA patients (p <0.05). Occurrence of back pain before the age of 40 was observed in 60% of axPsA cases, compared to 86.7% in OV axSpA (p<0.05). The limitation of spinal and hip mobility was less severe in axPSA than in OV axSpA. The median side flexion was 12.3 [10; 15] and 9.5 [8; 11] cm, the Schober test was 4.2 [3; 5] and 3.0 [2; 4] cm and intermalleolar distance was 95.9 [86; 102] and 83.0 [75; 100] cm, respectively (p<0.05). Patients with axPsA were more likely to have peripheral arthritis compared to patients with OV axSpA: 27 (90%) and 11 (36.7%) cases, respectively (p<0.05) and higher laboratory indices of activity: median ESR, 31.9 [10; 38] and 20.4 [5; 14] mm/h, and CRP, 20.5 [2.8; 20.7] and 13.6 [0.9; 12.0] mg/L, respectively (p<0.05). In the axPsA and OV axSpA groups, circulatory system diseases were found in 50 and 50% of patients, metabolic disorders in 76.6 and 76.6%, and gastrointestinal diseases in 46.7 and 70 %. Obesity was more common in axPsA than in OV axSpA – in 40 and 16.7% of patients, respectively (p<0.05).Conclusion. A high frequency of comorbidities, mainly cardiovascular and metabolic diseases, was found in both groups. These data should be considered in the choice of therapy and optimization of existing treatment algorithms.
format Article
id doaj-art-db000daee2ad41dfbf14ca2ddd86a234
institution Kabale University
issn 1996-7012
2310-158X
language Russian
publishDate 2024-10-01
publisher IMA-PRESS LLC
record_format Article
series Современная ревматология
spelling doaj-art-db000daee2ad41dfbf14ca2ddd86a2342025-08-20T03:59:56ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2024-10-01185223010.14412/1996-7012-2024-5-22-302715Comparative analysis of the frequency of comorbid diseases in axial psoriatic arthritis and other variants of axial spondyloarthritis. Data from a hospital cohortA. A. Yanushonite0Yu. L. Korsakova1T. V. Korotaeva2E. E. Gubar3E. Yu. Loginova4M. M. Urumova5A. E. Dimitreva6S. I. Glukhova7V.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyObjective: to compare the frequency of comorbid diseases in axial psoriatic arthritis (axSpA) and in other variants (OV) of axial spondyloarthritis (axSpA).Material and methods. We studied 60 patients, 30 with axPsA (15 men and 15 women, mean age – 49.1±10.4 years, disease duration – 12.6±6.9 years) and 30 with OV axSpA (16 men and 14 women, mean age – 42.9±9.7 years, disease duration – 16.30±8.3 years). All patients underwent a standard rheumatological examination. The diagnosis of comorbid diseases was confirmed using ICD-10 codes. The Cumulative Illness Rating Scale (CIRS), Charlson comorbidity index (CCI) and the weighted version of Functional Comorbidity Index (w-FCI) were used to assess comorbidity.Results and discussion. Comparative analysis of the two groups revealed that axPsA patients were older than OV axSpA patients (p <0.05). Occurrence of back pain before the age of 40 was observed in 60% of axPsA cases, compared to 86.7% in OV axSpA (p<0.05). The limitation of spinal and hip mobility was less severe in axPSA than in OV axSpA. The median side flexion was 12.3 [10; 15] and 9.5 [8; 11] cm, the Schober test was 4.2 [3; 5] and 3.0 [2; 4] cm and intermalleolar distance was 95.9 [86; 102] and 83.0 [75; 100] cm, respectively (p<0.05). Patients with axPsA were more likely to have peripheral arthritis compared to patients with OV axSpA: 27 (90%) and 11 (36.7%) cases, respectively (p<0.05) and higher laboratory indices of activity: median ESR, 31.9 [10; 38] and 20.4 [5; 14] mm/h, and CRP, 20.5 [2.8; 20.7] and 13.6 [0.9; 12.0] mg/L, respectively (p<0.05). In the axPsA and OV axSpA groups, circulatory system diseases were found in 50 and 50% of patients, metabolic disorders in 76.6 and 76.6%, and gastrointestinal diseases in 46.7 and 70 %. Obesity was more common in axPsA than in OV axSpA – in 40 and 16.7% of patients, respectively (p<0.05).Conclusion. A high frequency of comorbidities, mainly cardiovascular and metabolic diseases, was found in both groups. These data should be considered in the choice of therapy and optimization of existing treatment algorithms.https://mrj.ima-press.net/mrj/article/view/1636axial psoriatic arthritisaxial spondyloarthritiscomorbiditycomorbidity index
spellingShingle A. A. Yanushonite
Yu. L. Korsakova
T. V. Korotaeva
E. E. Gubar
E. Yu. Loginova
M. M. Urumova
A. E. Dimitreva
S. I. Glukhova
Comparative analysis of the frequency of comorbid diseases in axial psoriatic arthritis and other variants of axial spondyloarthritis. Data from a hospital cohort
Современная ревматология
axial psoriatic arthritis
axial spondyloarthritis
comorbidity
comorbidity index
title Comparative analysis of the frequency of comorbid diseases in axial psoriatic arthritis and other variants of axial spondyloarthritis. Data from a hospital cohort
title_full Comparative analysis of the frequency of comorbid diseases in axial psoriatic arthritis and other variants of axial spondyloarthritis. Data from a hospital cohort
title_fullStr Comparative analysis of the frequency of comorbid diseases in axial psoriatic arthritis and other variants of axial spondyloarthritis. Data from a hospital cohort
title_full_unstemmed Comparative analysis of the frequency of comorbid diseases in axial psoriatic arthritis and other variants of axial spondyloarthritis. Data from a hospital cohort
title_short Comparative analysis of the frequency of comorbid diseases in axial psoriatic arthritis and other variants of axial spondyloarthritis. Data from a hospital cohort
title_sort comparative analysis of the frequency of comorbid diseases in axial psoriatic arthritis and other variants of axial spondyloarthritis data from a hospital cohort
topic axial psoriatic arthritis
axial spondyloarthritis
comorbidity
comorbidity index
url https://mrj.ima-press.net/mrj/article/view/1636
work_keys_str_mv AT aayanushonite comparativeanalysisofthefrequencyofcomorbiddiseasesinaxialpsoriaticarthritisandothervariantsofaxialspondyloarthritisdatafromahospitalcohort
AT yulkorsakova comparativeanalysisofthefrequencyofcomorbiddiseasesinaxialpsoriaticarthritisandothervariantsofaxialspondyloarthritisdatafromahospitalcohort
AT tvkorotaeva comparativeanalysisofthefrequencyofcomorbiddiseasesinaxialpsoriaticarthritisandothervariantsofaxialspondyloarthritisdatafromahospitalcohort
AT eegubar comparativeanalysisofthefrequencyofcomorbiddiseasesinaxialpsoriaticarthritisandothervariantsofaxialspondyloarthritisdatafromahospitalcohort
AT eyuloginova comparativeanalysisofthefrequencyofcomorbiddiseasesinaxialpsoriaticarthritisandothervariantsofaxialspondyloarthritisdatafromahospitalcohort
AT mmurumova comparativeanalysisofthefrequencyofcomorbiddiseasesinaxialpsoriaticarthritisandothervariantsofaxialspondyloarthritisdatafromahospitalcohort
AT aedimitreva comparativeanalysisofthefrequencyofcomorbiddiseasesinaxialpsoriaticarthritisandothervariantsofaxialspondyloarthritisdatafromahospitalcohort
AT siglukhova comparativeanalysisofthefrequencyofcomorbiddiseasesinaxialpsoriaticarthritisandothervariantsofaxialspondyloarthritisdatafromahospitalcohort